Determine the necessary mass, volume, or concentration for preparing a solution.
≥98% for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
Protected from light,Store at -20°C,Argon charged Ships Ice chest + Ice pads Check lot-specific COA for exact specifications.
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
Cited in 5 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
D-Luciferin is mainly produced in bioluminescent organisms. It can simply circulate across the blood testis barrier, blood brain barrier and the blood placenta barrier. This small molecule is sensitive to light and oxygen. D-Luciferin is also sensitive to moisture in its powder form.
Application
D-Luciferin sodium salt has been used as a substrate in luciferin−luciferase chemiluminescence assay to determine ATP levels.
Substrate for firefly luciferase with a Km of approx 2 μM.
| Pubchem Sid | 488192435 |
|---|---|
| Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488192435 |
| Canonical Smiles | C1C(N=C(S1)C2=NC3=C(S2)C=C(C=C3)O)C(=O)[O-].[Na+] |
| IUPAC Name | sodium;(4S)-2-(6-hydroxy-1,3-benzothiazol-2-yl)-4,5-dihydro-1,3-thiazole-4-carboxylate |
| InChIKey | LILQLBIQROYWIA-OGFXRTJISA-M |
| INCHI | 1S/C11H8N2O3S2.Na/c14-5-1-2-6-8(3-5)18-10(12-6)9-13-7(4-17-9)11(15)16;/h1-3,7,14H,4H2,(H,15,16);/q;+1/p-1/t7-;/m1./s1 |
| Isomeric SMILES | C1[C@@H](N=C(S1)C2=NC3=C(S2)C=C(C=C3)O)C(=O)[O-].[Na+] |
| WGK Germany | 3 |
| Molecular Weight | 302.3 |
| Reaxy-Rn | 62728073 |
| Reaxys-RN_link_address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=62728073&ln= |
Comprehensive hazard, handling, storage, and regulatory compliance document.
Download SDS →Lot-specific quality data. Enter your lot number to retrieve the exact COA.
Look up COA →Full quality attributes and acceptance criteria for this grade.
View spec sheet →Taxonomy Tree
| Kingdom | Organic compounds |
|---|---|
| Superclass | Organic acids and derivatives |
| Class | Carboxylic acids and derivatives |
| Subclass | Amino acids, peptides, and analogues |
| Intermediate Tree Nodes | Amino acids and derivatives - Alpha amino acids and derivatives |
| Direct Parent | Cysteine and derivatives |
| Alternative Parents | Benzothiazoles 1-hydroxy-2-unsubstituted benzenoids Imidothiolactones Thiazolines Thiazoles Heteroaromatic compounds Carboxylic acid salts Sulfenyl compounds Propargyl-type 1,3-dipolar organic compounds Organic alkali metal salts Monocarboxylic acids and derivatives Imidothioic acids and derivatives Azacyclic compounds Organopnictogen compounds Organooxygen compounds Organonitrogen compounds Organic oxides Hydrocarbon derivatives |
| Molecular Framework | Aromatic heteropolycyclic compounds |
| Substituents | Cysteine or derivatives - 1,3-benzothiazole - 1-hydroxy-2-unsubstituted benzenoid - Imidothiolactone - Benzenoid - Heteroaromatic compound - Meta-thiazoline - Thiazole - Azole - Imidothioester - Carboxylic acid salt - Azacycle - Organic alkali metal salt - Organic metal salt - Organoheterocyclic compound - Organic 1,3-dipolar compound - Propargyl-type 1,3-dipolar organic compound - Sulfenyl compound - Monocarboxylic acid or derivatives - Imidothioic acid or derivatives - Organic nitrogen compound - Organic oxygen compound - Organopnictogen compound - Organic oxide - Hydrocarbon derivative - Organic salt - Organosulfur compound - Organooxygen compound - Organonitrogen compound - Aromatic heteropolycyclic compound |
| Description | This compound belongs to the class of organic compounds known as cysteine and derivatives. These are compounds containing cysteine or a derivative thereof resulting from reaction of cysteine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. |
| External Descriptors | Not available |
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Mar 24, 2026 | D115509 | |
| Certificate of Analysis | Mar 24, 2026 | D115509 | |
| Certificate of Analysis | Mar 24, 2026 | D115509 | |
| Certificate of Analysis | Mar 24, 2026 | D115509 | |
| Certificate of Analysis | Jul 16, 2025 | D115509 | |
| Certificate of Analysis | Jul 16, 2025 | D115509 | |
| Certificate of Analysis | Jul 16, 2025 | D115509 | |
| Certificate of Analysis | Jul 16, 2025 | D115509 | |
| Certificate of Analysis | Jul 16, 2025 | D115509 | |
| Certificate of Analysis | May 14, 2024 | D115509 | |
| Certificate of Analysis | Sep 22, 2023 | D115509 | |
| Certificate of Analysis | Aug 10, 2023 | D115509 | |
| Certificate of Analysis | May 10, 2023 | D115509 | |
| Certificate of Analysis | May 10, 2023 | D115509 | |
| Certificate of Analysis | May 10, 2023 | D115509 | |
| Certificate of Analysis | May 10, 2023 | D115509 | |
| Certificate of Analysis | May 10, 2023 | D115509 | |
| Certificate of Analysis | May 10, 2023 | D115509 | |
| Certificate of Analysis | May 10, 2023 | D115509 | |
| Certificate of Analysis | Mar 09, 2023 | D115509 | |
| Certificate of Analysis | Nov 22, 2022 | D115509 | |
| Certificate of Analysis | Nov 22, 2022 | D115509 | |
| Certificate of Analysis | Nov 22, 2022 | D115509 | |
| Certificate of Analysis | Nov 22, 2022 | D115509 | |
| Certificate of Analysis | Nov 22, 2022 | D115509 | |
| Certificate of Analysis | Nov 22, 2022 | D115509 | |
| Certificate of Analysis | Nov 22, 2022 | D115509 | |
| Certificate of Analysis | Nov 22, 2022 | D115509 | |
| Certificate of Analysis | Nov 22, 2022 | D115509 | |
| Certificate of Analysis | Nov 22, 2022 | D115509 | |
| Certificate of Analysis | Nov 22, 2022 | D115509 | |
| Certificate of Analysis | Oct 11, 2022 | D115509 | |
| Certificate of Analysis | Oct 11, 2022 | D115509 | |
| Certificate of Analysis | Oct 11, 2022 | D115509 | |
| Certificate of Analysis | Oct 11, 2022 | D115509 | |
| Certificate of Analysis | Oct 11, 2022 | D115509 | |
| Certificate of Analysis | Feb 18, 2022 | D115509 |
| Solubility | Soluble in water (10 mg/ml), ethanol (~0.25 mg/ml), DMSO (~10 mg/ml), DMF (~16.7 mg/ml), and PBS pH 7.2 (~10 mg/ml). |
|---|---|
| Sensitivity | light & Moisture sensitive |
| Molecular Weight | 302.300 g/mol |
| XLogP3 | |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 2 |
| Exact Mass | 301.98 Da |
| Monoisotopic Mass | 301.98 Da |
| Topological Polar Surface Area | 139.000 Ų |
| Heavy Atom Count | 19 |
| Formal Charge | 0 |
| Complexity | 396.000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 0 |
| Covalently-Bonded Unit Count | 2 |
| 1. Xiao Kui, Zhang Niyuan, Li Feifei, Hou Dayong, Zhai Xiaoyi, Xu Wanhai, Wang Gelin, Wang Hao, Zhao Liang. (2022) Pro-oxidant response and accelerated ferroptosis caused by synergetic Au(I) release in hypercarbon-centered gold(I) cluster prodrugs. Nature Communications, 13 (1): (1-13). [PMID:35945240] [10.1038/s41467-022-32474-y] |
| 2. Chao Chen, Hongxia Zhang, Lingling Qi, Haoqi Lei, Xuefei Feng, Yingjie Chen, Yuanyuan Cheng, Defeng Pang, Jufeng Wan, Haiying Xu, Shifeng Cao, Baofeng Yang, Yan Zhang, Xin Zhao. (2025) Obesity-driven oleoylcarnitine accumulation in tumor microenvironment promotes breast cancer metastasis-like phenotype. Acta Pharmaceutica Sinica B, [PMID:40486851] [10.1016/j.apsb.2025.02.026] |
| 3. Song Zhengwei, Sun Quanwei, Yang Wenshuo, Li Yunlong, Hu Chaoyu, Chen Chen, Liu Kang, Shen Wei, Yang Ye, Yin Dengke. (2025) Inflammation-targeted nanomedicine prevents tumor metastasis following photodynamic therapy by reversing epithelial-mesenchymal transition and ROS-mediated immunosuppression. JOURNAL OF NANOBIOTECHNOLOGY, 23 (1): (1-19). [PMID:40186261] [10.1186/s12951-025-03332-y] |
| 4. Dong-Ni Pei, Yang Song, Ying-Xia Zhou, Bo Shu, Shao-wei Huang, Fa-Zhao Li, Wei-Dong Dai, Bao-Ye Sun. (2025) Enhancing cDC1-mediated anti-tumor immunity limits tumor progression and potentiates anti-PD-1 therapy in intrahepatic cholangiocarcinoma. Frontiers in Immunology, [PMID:41459487] [10.3389/fimmu.2025.1708962] |
| 5. Xianghua Zhong, Xinchao Liu, Jiajia Luo, Xinyang Liu, Xueting Wei, Xi Peng, Lu Wang, Huaimin Wang, Kunyu Zhang, Liming Bian, Peng Shi. (2026) Cell surface engineering with a pseudofibrotic ECM reprograms the antifibrotic activity of mesenchymal stromal cells. Science Advances, 12 (3): [PMID:41544160] [10.1126/sciadv.aea0998] |